Janus kinase inhibitors ameliorate clinical symptoms in patients with STAT3 gain-of-function.
Saved in:
| Title: | Janus kinase inhibitors ameliorate clinical symptoms in patients with STAT3 gain-of-function. |
|---|---|
| Authors: | Kaneko S; Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan., Sakura F; Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan., Tanita K; Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan., Shimbo A; Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan., Nambu R; Division of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan., Yoshida M; Division of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan., Umetsu S; Department of Pediatric Hepatology and Gastroenterology, Saiseikai Yokohama-shi Tobu Hospital, Kanagawa, Japan., Inui A; Department of Pediatric Hepatology and Gastroenterology, Saiseikai Yokohama-shi Tobu Hospital, Kanagawa, Japan., Okada C; Hiroshima Chuodori Children Clinic, Hiroshima, Japan., Tsumura M; Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan., Yamada M; Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan., Suzuki H; Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan., Kosaki K; Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan., Ohara O; Department of Technology Development, Kazusa DNA Research Institute, Chiba, Japan., Shimizu M; Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan., Morio T; Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan., Okada S; Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan., Kanegane H; Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. |
| Source: | Immunotherapy advances [Immunother Adv] 2023 Nov 24; Vol. 3 (1), pp. ltad027. Date of Electronic Publication: 2023 Nov 24 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101776979 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-4303 (Electronic) Linking ISSN: 27324303 NLM ISO Abbreviation: Immunother Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
